π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
Prolgolimab is an anti-PD-1 inhibitor that has previously been shown to be ...
Status
Unknown
Location
St. Petersburg State Pavlov Medical University
Start Date
2023-04-19
Trial ID
NCT05757466
Treatments Being Tested
In this phase II study patients with stage II-III MSI/dMMR colorectal adeno...
Status
Completed
Location
N.N. Blokhin NMRCO
Start Date
2022-03-31
Trial ID
NCT06428487
Treatments Being Tested
Multicentre, single-arm, open-label efficacy, pharmacokinetics, and safety ...
Status
Unknown
Location
State Budgetary Institution of Healthcare of the Arkhangelsk Region "Arkhangelsk Regional Clinical Oncology Dispensary" (SBHI AR ARCOD)
Start Date
2022-02-01
Trial ID
NCT05783882
Treatments Being Tested
Describe the safety, tolerability, efficacy and approaches to prescribing p...
Status
Unknown
Location
N.N. Blokhin National Medical Research Center of Oncology
Start Date
2020-10-14
Trial ID
NCT05120024
This study is an open-label, randomized, comparative phase III study, which...
Status
Active Not Recruiting
Location
State Institution "Republican Scientific and Practical Center of Oncology and Medical Radiology named after A.I. N.N. Alexandrov"
Start Date
2023-04-05
Trial ID
NCT05751928
Treatments Being Tested
The aim of study is to investigate the efficacy, safety, immunogenicity, ph...
Status
Active Not Recruiting
Location
Healthcare Institution "Bobruisk Interdistrict Oncological Dispensary"
Start Date
2022-08-02
Trial ID
NCT05732805